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Studies have been conducted on various factors and their effect on human papillomavirus (HPV) 
vaccination uptake amongst adolescents. However, these studies typically point to 
communication factors and provider recommendations as having a significant effect on HPV 
vaccination uptake, ultimately leading to the need for more information on other factors that may 
increase HPV vaccination amongst adolescents. The purpose of this quantitative cross-sectional 
study was to determine if race, provider-location type, and region of the United States have a 
statistically significant effect on HPV uptake amongst adolescents. The 2018 National 
Immunization Survey (NIS) was used, and 34,980 participants were included in the sample. The 
theoretical framework used for this study was Hochman and Rosentsock’s Health Belief Model 
(HBM). The HBM approach was used to explore the health behavior change process and the 
attitudes and perceptions amongst parents that are associated with HPV vaccination uptake 
amongst adolescents. Using the cross-sectional design, surveys from the NIS were analyzed 
using a binary logistic regression to determine whether race, provider-location type, and region 
of the United States have a statistically significant effect on HPV vaccination uptake amongst 
adolescents. The results of these analyses indicated that there was a statistically significant effect 
amongst race and region. Specifically, the White race residing in the Northeast, Midwest, and 
Southern regions were shown to have a statistically significant effect and an upward uptake on 
HPV vaccination amongst adolescents. Public health professionals and providers may benefit 
from the results of this study by identifying the areas that are shown to have a statistically 
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Chapter 1: Introduction to the Study 
Background of the Study 
The human papillomavirus (HPV) vaccine is an essential element in the 
prevention of cancer and has the ability to save lives. HPV is a vaccine that is needed, but 
not always consistently administered. HPV affects approximately 14 million people in the 
United States each year and has the ability to cause certain types of cancers in both men 
and women (CDC, 2017).  The cancers most commonly associated with HPV include 
cancer of the cervix, oropharyngeal, vulva, vagina, penis, and anus (CDC, 2017). 
HPV is the most common sexually transmitted infection, and due to its 
prevalence, it is predicted that all persons that are sexually active will get the virus at a 
point in their lives if they have not received the HPV vaccine (CDC, 2017). 
Unfortunately, HPV vaccination rates in the United States have consistently staggered in 
comparison to other vaccines (CDC, 2017). In 2017, only 49% of adolescents were up to 
date on the HPV vaccine, and 66% of adolescent’s ages 13 to 17 received the first dose of 
the HPV vaccine series (CDC, 2018). Although research has been conducted on the 
communication factors of HPV, there is limited research on the specific factors that affect 
HPV vaccine uptake in adolescents. No research was found that looked into determining 
whether there were specific factors such as race, geographical region, and provider-
location type in a cohesive manner.  
A retrospective analysis of existing data can provide a look into whether there are 
factors that affect HPV vaccine uptake among adolescents. The aim of this study was to 





the United States, and provider-location type on HPV vaccination uptake amongst 
adolescents. 
Problem Statement 
Vaccine misconceptions occur frequently, and health care providers can play a 
significant role in addressing fallacies. Communication about HPV vaccination occurs in 
several ways, from direct conversations with providers and nurses to outreach from state 
and local health departments (Hendrix, 2015). Currently, no studies exist that aid in 
determining the cohesive effect of race, provider-location type, and geographical region 
of the United States, on HPV vaccination uptake in adolescents. As mentioned 
previously, the aim of this study was to determine the correlational effect of provider-
location type, race, and geographical region to identify trends related to racial disparities 
and regional provider health practices regarding HPV vaccine uptake among adolescents. 
I sought to create further research through identifying specific strategies related to 
reaching all racial groups and identifying regional-provider-locations, through possible 
outlining of provider HPV uptake practices in areas of higher uptake.  
Purpose Statement 
The purpose of this quantitative study was to determine if certain races and 
regions of the country have a significant effect on HPV vaccine uptake in adolescents. It 
was also important to determine specific racial and relational factors that may lead to a 
higher HPV vaccination rate, for further research. Factors may include educational 
barriers, socioeconomic factors, provider relationship, and/or outreach initiatives. I 
employed a quantitative research methodology using secondary data. I retrieved the data 





sponsored by the Centers for Disease Control and Prevention’s (CDC) National Center 
for Immunization and Respiratory Diseases (NCIRD; CDC, 2018).  
Research Questions and Hypotheses 
RQ1: What is the effect of race and region of the United States on HPV vaccine 
uptake in adolescents? 
H01: There is no effect of race and region of the United States on HPV vaccine 
uptake in adolescents. 
H0a: There is a significant effect of race and region of the United States on HPV 
vaccine uptake in adolescents. 
RQ2: What is the effect of race and provider-location type on HPV vaccine 
uptake in adolescents? 
H01: There is no effect of race and provider-location type on HPV vaccine uptake 
in adolescents. 
H0a: There is a significant effect of race and provider-location type on HPV 
vaccine uptake in adolescents. 
RQ3: What is the effect of region of the United States and provider-location type 
on HPV vaccine uptake in adolescents? 
H01: There is no effect of region of the United States and provider-location type 
on HPV vaccine uptake in adolescents. 
H0a: There is a significant effect of region of the United States and provider-
location type on HPV vaccine uptake in adolescents. 
RQ4: Does race modify the effect of region of the United States on HPV vaccine 





H01: Race does not modify the effect of region of the United States on HPV 
vaccine uptake in adolescents. 
H0a: Race significantly modifies the effect of region of the United States on HPV 
vaccine uptake in adolescents. 
Nature of the Study  
This research examined how race, provider-location type, and region of the 
United States affects HPV vaccine uptake among adolescents. Quantitative methods are 
more objective than alternative approaches. This approach is consistent with 
understanding the research questions. To achieve the anticipated results, the NIS was 
used to address the research questions (CDC, 2018). Descriptive statistics were 
conducted to summarize the data. Additionally, a Pearson chi-square analysis was 
conducted to determine if there is a relationship between the variables, and a binary 
logistic regression analysis was conducted to determine the effect of race, provider-
location type, and region of the United States on HPV vaccine uptake among adolescents.  
Definition of Terms 
 The definition of key terms used throughout this study are shown below. 
Human Papillomavirus (HPV):  A small, double-stranded DNA virus that infects 
the epithelium. It is estimated that there are more than 120 HPV types (CDC, 2019). HPV 
is also the most common sexually transmitted infection in the United States (CDC, 2019). 
Epidemiologic studies showing a consistent association between HPV and cervical cancer 
were published in the 1990s (CDC, 2019). 
HPV Vaccine: There are three HPV vaccines licensed in the United States (CDC, 





Gardasil and manufactured by Merck, in 2006 (CDC, 2019). The bivalent HPV (HPV2) 
vaccine, also known as Cervarix, was approved by the FDA and manufactured by 
GlaxoSmithKline in October 2009 (CDC, 2019). 
Race: The Census Bureau defines race as “a person's self-identification with one 
or more social groups” (Census.gov, 2017). An individual can report to be White, Black 
or African American, Asian, American Indian and Alaska Native, Native Hawaiian and 
Other Pacific Islander, or some other race (Census.gov, 2017).  
Provider-location type: For the purpose of this research study, provider-location 
type is defined as a place in which a vaccine is administered, which may include a 
hospital, health department, doctor’s office, pharmacy, etc.  
Geographical/Census Region of the United States: A region is an area of land that 
has common features. Regions of the United States are commonly grouped into five 
geographic locations: The Northeast, Southwest, West, Southeast, and Midwest (National 
Geographic, 2019). 
Theoretical Framework  
The Health Belief Model (HBM) developed by Hochman and Rosenstock was 
ideal for this study because it allows researchers to understand the health behavior change 
process. The HBM was developed to identify the attitudes of parents and providers 
toward HPV vaccination and what types of provider-locations, races, and geographical 
regions may affect those attitudes. Factors such as low risk perception may be a barrier to 
HPV vaccine uptake amongst adolescents; therefore, it was important to identify the 
effects of certain factors that may lead to understanding the barriers, benefits, self-





importance (Jones, Jensen, Scherr, & et al , 2015). The HBM implies that a specific 
health action will prevent or cure illness (LaMorte, 2018). There are several constructs 
that comprise the HBM: perceived susceptibility, a parent’s perception of the risk of the 
HPV vaccine; perceived severity, the parent’s feelings on the seriousness of their child 
contracting HPV; perceived benefits, the parent’s perception of the effectiveness of 
vaccination; perceived barriers, a parent’s feelings towards the obstacles to receiving the 
HPV vaccine; and cue to action, the need to trigger the parent to make the decision to 
vaccinate child against HPV. 
Significance 
Healthcare providers play an important role in educating patients and parents on 
the importance of HPV vaccination. Studies have consistently shown that non-existent or 
weak recommendations from health care providers are primary determinants of poor 
vaccine uptake (Ventola, 2016). As a result, it is important to develop interventions that 
target health care providers and their practices, including patient counseling, vaccine 
forecasting, and reminder systems (Ventola, 2016). In order to determine what providers 
are more effective in educating and administering HPV vaccination in adolescents, it was 
important to understand what type of provider-location types and what regional areas of 
the country were more successful in HPV uptake. It was also equally vital to determine 
the racial barriers associated with HPV vaccine. Race-specific factors can help or hinder 
vaccination rates in certain areas. It was also important to determine whether there was a 
relationship between certain provider-location types and race. The aim of this study was 
to open the path for further research in health promotion, identifying barriers, and 





Implications for Social Change 
Social change is about making a positive impact on society (Walden University, 
2017). The potential social change impact of this study was the prevention of cancer. 
Strengthening the overall understanding of the impact of HPV prevention is important for 
fostering positive social change. Identifying specific racial barriers and provider-locations 
most affected while creating specified ways to increase HPV vaccination rates around the 
country will aid in preventing HPV-related cancer deaths of citizens of the United States, 
which in turn will aid in preventing HPV-related cancer deaths around the world. This 
study sought to create the ultimate positive impact on society through saving lives. 
Assumptions 
When discussing the assumptions of this study, it was important to factor in the 
characteristics of the data, as well as the sample size. The study’s sample may not be 
representative of the population; however, it was my assumption that the sample size was 
a good representation of the population. I also assumed that individuals completing the 
survey were being truthful and that answers received at the time of the survey were 
verified for accuracy.  
Scope and Delimitations 
The scope of this study included parents of adolescent children across the United 
States. This group was targeted due to the age in which adolescents are recommended to 
receive the HPV vaccine, which is the ages of 11 and 12. The age group of this sample is 
13 to17 which falls after the recommended age, to factor in adolescents who may have 





groups because they would not apply to the recommended age for HPV vaccine 
acquisition, therefore causing issues with validity.  
Limitations 
The limitations of this study included the inability to conclusively attribute race, 
geographical region of the United States, and/or provider-location type to an increased 
uptake in HPV vaccination. An additional limitation of this study was that the sample 
was not representative of the entire population. It is important to understand this 
limitation as the NIS does not survey the entire population. Additional barriers may have 
been produced as a result of inaccurate reporting, which would reduce validity.   
Summary 
This chapter discussed the causality and etiology of HPV. This chapter also 
explored the importance of the HPV vaccine and the growing concern regarding the low 
uptake amongst adolescents. HPV can adversely affect so many lives, however, we are 
fortunate to have developed a vaccine that is available to adolescents. We are also 
fortunate to have a public health advance with the use of the HPV vaccine that can 
prevent HPV and ultimately varying types of cancers in all genders. HPV vaccine 
administration falls behind other recommended vaccines but has the potential to prevent 
frequent infection and save lives. Therefore, it was important to understand the factors 
and barriers that may affect the uptake in adolescents. This study was aimed at 






Chapter 2: Literature Review 
Introduction 
HPV is the most common sexually transmitted infection in the United States and 
has the ability to cause frequent infection and several forms of cancer (Centers for 
Disease Control and Prevention, CDC, n.d.). HPV vaccination rates in the United States 
remain low compared to other recommended vaccines such as Tdap. There are several 
factors that contribute to the low uptake of HPV vaccination. The purpose of this 
literature review was to understand and expand on the existing knowledge surrounding 
the factors effecting HPV vaccine uptake in adolescents.  
This literature review discusses the theoretical framework relevant to this study, 
the etiology of HPV, and the mode of prevention. I intended to identify racial and 
regional factors that influence HPV uptake in adolescents as revealed in previous studies. 
The literature review also looks into HPV, vaccination strategies, and physician 
recommendation. There was insufficient research that identified provider-location type 
and its effect, if any, on HPV uptake in adolescents in the United States. There was also 
no research found regarding the aforementioned factors cohesively having an effect on 
HPV uptake amongst adolescents. This literature review also details overall findings and 
trends to gain a better understanding of what previous research discovered.  
Literature Search Strategy 
My review of the literature identified scholarly articles published between 2015 
and 2020. To conduct the literature review, I searched the Walden University Library 
along with the following online databases: ProQuest, MEDLINE, PubMed, EBSCOHost, 





Boolean search string composed of the following key terms: HPV, human papillomavirus 
vaccine, HPV vaccine uptake AND adolescents AND barriers, HPV Vaccine uptake AND 
race AND adolescents, HPV vaccine uptake AND adolescents AND provider location 
type, HPV Vaccine uptake AND adolescents AND geographical region, and HPV vaccine 
uptake AND United States. Various other articles were located using the references of 
related studies. 
The literature screening process included reviewing the abstracts of each article to 
determine if it met the criteria for inclusion in this literature review. Articles were 
excluded based on the following factors: if they were published prior to 2015, if the study 
was conducted outside of the United States, and if the article was not relevant to HPV 
vaccination uptake. Articles that were reviewed in their entirety provided insight into the 
research that has been conducted surrounding the topic of this dissertation.  
Theoretical Framework 
The HBM was the ideal theoretical framework for this study. The HBM was 
developed to understand the process of health behavior (Rosenstock, 1974). The HBM 
was created from independent and applied public health service research problems 
between 1950-1960, and as practical problems were solved, the HBM evolved 
(Rosenstock, 1974). In the 1950s, patient compliance and physician-patient 
communication were not a consideration of the public health realm, and during this time, 
individuals often did not comply with disease prevention measures and test screenings for 





developed to address these factors by explaining and targeting preventative behavior 
prior to the potential onset of disease (Rosenstock, 1974).  
The HBM will aid in identifying the attitudes of parents and providers toward 
HPV vaccination as a preventative measure and will ultimately identify how the specified 
factors may affect the proposed and intended behavior change. The HBM will assist in 
addressing the importance of targeted audiences, provider-relationship, and rapport, and 
could indicate whether knowledge, accessibility, race, region, and provider-location lead 
to a higher uptake of HPV vaccine amongst adolescents. Table 1 depicts the constructs in 
relation to HPV vaccine uptake regarding this study.  
Table 1 







A person’s perception of the 
risk of acquiring a disease. 
 
Parents’ perception of 
adolescent child acquiring HPV, 
due to factors of race, 





A person’s feelings on the 
seriousness of contracting a 
disease 
 
Parents’ feelings on the severity 
of their adolescent child 
contracting HPV, which may be 
affected by factors such as race, 





A person’s perception of the 
effectiveness of various 
actions available to reduce 
the threat of illness or 
disease  
 
Factors that may affect the 
parent’s perception of the 
effectiveness of the HPV 








A person’s feelings on the 
obstacles to performing a 
recommended health action. 
 
Factors contributing to the 
obstacles to acquiring HPV 
vaccination for their adolescent 
child. 
Cues to action 
 
Stimulus needed to trigger the 
decision-making process to 
accept a recommended health 
action. 
 
Strategies to trigger the decision 
to acquire the HPV vaccine for 
adolescent child.  
Self-efficacy 
 
The level of a person’s 
confidence in his or her 
ability to successfully 
perform a behavior. 
 
Parents’ confidence in their 
ability to successfully have their 
adolescent child vaccinated. 
(Rosenstock, 1974). 
 
 Previously, the HBM had been used to predict a health behavior based on a 
person feelings, knowledge, beliefs, or attitudes. For instance, the HBM was used to 
investigate the effect of educational programs on nursing students’ health beliefs and 
practices of breast self-examination (Kissal & Kartal, 2019). Other researchers have used 
it to explore the predictors of Haitian men’s intention to screen for prostate cancer (Louis, 
2019).  It has been found that education has a positive influence on the frequency of 
breast self-examination, the HBM will aid in understanding how a person’s knowledge 
can influence behavior change (Kissal & Kartal, 2019). It has also been found that culture 
can be a barrier to individual’s decision to screen for prostate cancer (Louis, 2019).    
The HBM provides a process of behavior change evolution. It begins with the 
belief or attitude, followed by education and knowledge, and finally by confidence and 
ability. It facilitated understanding of the attitudes towards HPV and how specific factors 
affected those attitudes, cohesively. Understanding how race, geographical location, and 





aforementioned assisted in identifying strategies and interventions that can be used to 
increase vaccination amongst the barriers and to identify a target population to reach this 
feat.  
Review of Literature Related to Key Variables and Concepts 
Human Papillomavirus Information 
HPV are double-stranded DNA viruses that infect the basal, cutaneous, and 
mucosal epithelium. Of the more than 120 HPV types, 40 types infect the mucosal 
epithelium and have been found to correlate with cervical carcinoma (CDC, n.d.). There 
are over 13 cancerous high-risk HPV types, with 70% of cervical cancer being attributed 
to types 16 and 18, accounting (Ault, 2006). HPV infection incidence is high and 
typically asymptomatic, however the virus generally heals on its own, while some other 
individuals become persistently infected which increases the risk for cervical cancer 
development, with the most significant being the cervical intraepithelial neoplasia, or 
CIN (Ault, 2006). The CIN can range from low-grade CIN 1 to high-grade CIN 3; the 
higher the grade, the higher the risk of cancer (Ault, 2006). In low-grade lesions, HPV is 
in episomal form, while in high-grade lesions and cancer, the HPV DNA is typically 
integrated into the host-cell chromosome (Ault, 2006). Figure 1 provides more 
information on HPV infection. 
The clinical manifestations of HPV infection include genital warts, recurrent 
respiratory papillomatosis, cervical cancer precursors, and various cancers including 






Figure 1. Human papillomavirus.  
(Centers for Disease Control and Prevention, n.d.). 
Human Papillomavirus Prevalence and Transmission 
There are approximately 79 million people in the United States currently infected 
with HPV, with sexual activity being the major risk factor for infection (CDC, n.d.). HPV 
spreads by direct sexual contact, and it is believed that by age 50, 80% of women will 






Figure 2: Natural history of HPV infection. 
(Centers for Disease Control and Prevention, n.d.). 
 HPV Vaccination Information 
Currently, there are three vaccines that prevent infection with disease-causing 
HPV types: quadrivalent vaccine Gardasil, nonavalent vaccine Gardasil 9, and bivalent 
vaccine Cervarix, all are licensed for use in the United States (Cancer.gov, 2019). Each of 
these vaccines prevent infection with the two high risk HPV types, 16 and 18. Gardasil 
prevents infection with HPV types 6 and 11, while Gardasil 9 prevents infection with the 
same four HPV types plus five additional cancer-causing types (31, 33, 45, 52, and 58) 
(Cancer.gov, 2019). Currently, Gardasil 9 is the only HPV vaccine available for use in 





United States ACIP HPV Vaccination Recommendation  
The Advisory Committee on Immunization Practices (ACIP) develops 
recommendations on vaccination to prevent and control vaccine preventable diseases in 
the United States. Once the ACIP formulates the recommendations the CDC director 
reviews the recommendations for approval, once approved the recommendations are 
published and adopted. (CDC, 2019). The ACIP recommends that HPV vaccination 
should be administered at the age of 11 or 12 years, however, vaccination can be started 
as early as age 9 years. HPV vaccination is recommended for all persons through age 26 
years who were not adequately vaccinated earlier (CDC, 2019). The Healthy People 2020 
target goal for adolescent HPV vaccination is 80% (National Vaccine Advisory 
Committee, 2016). 
Studies on HPV Vaccine and Physician Recommendation  
It has been proven across the literature that provider recommendations are one of 
the most important elements of HPV vaccine uptake amongst adolescents. Provider 
recommendations are not given consistently, the recommendations may not be timely, 
which increases missed opportunities, and are often not considered urgent, in regard to 
strong recommendations in receiving the vaccine prior to exposure to the infection 
(Sriram & Ranganathan, 2019). Researchers found that adolescents who are not 
recommended for vaccination by the family physician were 0.43 times less likely to get 
HPV vaccination compared to adolescents that were recommended to get the vaccination 
by the provider p = 0.000, OR 0.57, 95% CI [0.49, 0.65] (Sriram & Ranganathan, 2019).  
Shawhan and Ruppe (2019), mentioned that a firm and consistent 





opportunity to vaccinate and should be offered to patients just as other recommended 
vaccines (Shawhan & Ruppe, 2019). According to the 2015 study of National 
Immunization Survey–Teen national survey data, a significant predictor of HPV vaccine 
uptake was attributed to provider recommendation, even with patients and/or parents 
having common knowledge of the vaccine (Shawhan & Ruppe, 2019). Valentino and 
Poronsky (2016), mentioned that providers often fail to recommend HPV vaccination for 
adolescents, and typically provide weaker recommendations for HPV vaccination 
compared with other vaccinations recommended for adolescents; ultimately diminishing 
its importance (Valentino, & Poronsky, 2016). 
According to a study, provider recommendations among females were highest 
among non-Hispanic whites, while provider recommendations among males were lowest 
among non-Hispanic whites (Burdette et al, 2017). Hanson et al. (2019) mentioned that at 
follow-up, 65% of survey respondents reported receiving an HPV vaccine 
recommendation from a healthcare provider, 56% of respondents reported discussing 
HPV vaccine with their parents, and 55% had initiated the HPV vaccine series (Hanson, 
McLean, Belongia, & et al., 2019). Loke et al. (2017), mentioned that within the 42 
articles of conducted research, one-third reported that a major facilitator of HPV 
vaccination among adolescents was the healthcare provider or physician recommendation 
(Loke, & et al, 2017). Health care providers were considered to be the most trusted 
source of health information for parents and was a major determining factor for the 





Studies on HPV Vaccine and Provider-Location Type 
Garbutt et al. (2018) indicated that accurate characterization of the facilitators and 
barriers to implementation of HPV vaccine recommendations in the primary care setting 
has the ability to inform effective implementation strategies (Garbutt, Dodd, Walling & et 
al, 2018). A Consolidated Framework for Implementation Research (CFIR) was used to 
assess factors the aid in HPV vaccine influence in 10 primary care practices (Garbutt, 
Dodd, Walling & et al, 2018). The results showed strongly distinguishing constructs, of 
which included knowledge and beliefs, self-efficacy, readiness for change, perception, 
and the process to deliver the vaccine (Garbutt, Dodd, Walling, & et al, 2018). These 
constructs show the various significant barriers to HPV vaccination at the primary 
provider level. There are other provider types that may have the same barriers, and 
possibly more. This shows that addressing the HPV vaccine issue will be a multi-step and 
multi-prong approach, but first it is important to understand what providers are more or 
less successful to identify the strategies that can be adopted to effectively combat the low 
uptake of HPV vaccination amongst adolescents.  
Katz et al. (2016) indicated that further research should look into strategies are 
needed to support providers, including vaccine promotion and delivery while addressing 
HPV vaccination concerns for parents (Katz, Bogart, Fu, & et al, 2016). Additional areas 
of research include, collaboration at the practice level through standardization of 
reminder systems for better efficiency (Garbutt, Dodd, Walling & et al, 2018). Provider-
location has the ability to affect HPV vaccination uptake in adolescents. A study was 
conducted that incorporated an intervention bundle to include, empowerment of nurses, 





Griggs & et al, 2018). Overall, the implementation of this strategy led to a decrease in 
missed opportunities at an OB/GYN clinic and increased the initiation of HPV 
vaccination, this increase was significant amongst minority Hispanic, publicly insured 
and uninsured women (Deshmukh, Oliveira, Griggs & et al, 2018). This article provided 
a great deal of information; even though this was not a study targeted at adolescents, the 
strategy could still work amongst minority groups and amongst different provider-
location types. It is important to identify what works, and how to effectively identify the 
strategies that have worked according to previous research. This study provided more 
details into interventions that can contribute to effectiveness and an increase in HPV 
vaccination uptake amongst adolescents (Deshmukh, Oliveira, Griggs & et al, 2018).  
Studies on HPV Vaccination Strategies 
HPV vaccine strategies can provide insight into increasing HPV vaccination 
amongst adolescent while considering a variety of factors. Institutional and policy factors 
contribute positively to increasing uptake of HPV vaccine, school-based policies are also 
effective in achieving higher vaccination rates, however, this can be very complex with a 
vaccine such as HPV because it is not communicable in a school setting (Head, 
Biederman, Sturm, & Zimet, 2018). Vaccine policies also play a key role in increasing 
the uptake of HPV vaccination, due to efficacy of a 2 dose series, the reduction in the 
number of doses of HPV from 3 doses to 2 doses prior to age 15, may contribute to an 
increase in uptake as well as, completion of the series. Age-based policies may also 
increase the uptake of HPV amongst adolescents, the suggestion of moving the age of 
vaccination to an earlier age, may disassociate the vaccine with the initiation of sex 





anti-HPV vaccine rhetoric, HPV vaccine controversies are plentiful, with the belief that 
the vaccination will translate to increased sexual activity, and negative beliefs 
surrounding the vaccination (Head, Biederman, Sturm, & Zimet, 2018). Technology is 
also a great resource for increasing HPV vaccination, eHealth can assist in addressing 
HPV vaccination in a clinical setting, for example reminders, and forecasting of 
vaccination.  
Identifying which providers are using technological platforms such as eHealth can 
assist in determining the providers with an increased level of HPV vaccination amongst 
adolescents (Head, Biederman, Sturm, & Zimet, 2018).  Lastly, community-based 
interventions have the ability to increase vaccination among adolescents, effective 
communication can change the narrative and negative beliefs associated with the HPV 
vaccine; community-based interventions can also target a specific population in a specific 
area, amongst different providers, ultimately increasing HPV vaccination rates amongst 
adolescents (Head, Biederman, Sturm, & Zimet, 2018). Overall, it is important to identify 
strategies that will influence and educate on HPV vaccination. Establishing public policy, 
taking advantage of eHealth technologies, and creating effective communication, can 
assist in increasing HPV vaccine uptake amongst adolescents. Further research is needed 
to determine effective strategies that can lead to increased HPV vaccination, of which a 
multifaceted and multipronged approach seems to be ideal and would have the ability to 
address several of the barriers to increase HPV vaccine uptake through education, and 





Studies on HPV Vaccination and Race  
There are racial differences as it pertains to HPV vaccination amongst 
adolescents. There are variations among different races and the initiation of the HPV 
vaccine amongst adolescents. The study showed Hispanic adults were 1.47 times more 
likely to get vaccinated compared to non-Hispanic adolescents p = 0.000, OR 1.47, 95% 
CI [1.24, 1.74] (Sriram & Ranganathan, 2019). A study also found that Hispanic female 
adolescents initiated the HPV vaccine at a higher rate (48%), while African American 
adolescents had a lower rate of HPV vaccine initiation (40%) (Burdette, Webb, Hill & et 
al, 2017). Additionally, minority adolescent males had a higher rate of HPV vaccine 
initiation (12%) while non-Hispanic whites had lower HPV vaccination initiation (24%) 
(Burdette, Webb, Hill & et al, 2017). An investigation into collaborative communication 
and race was identified, it was found that this type of communication was less common 
for Hispanic than for non-Hispanic white girls, p<.05 (Moss, Gilkey, Rimer, & et al, 
2016). In regard to the attitudes toward HPV vaccination, Hispanic (versus White) 
parents placed greater importance on HPV vaccination to benefit their son’s future sex 
partners (b = .38). Black (b = .64) and Hispanic (b = .67; versus White) males reported 
higher individualistic vaccination importance (Polonnijo, Carpiano, Reiter, & Brewer, 
2016).  Henry, et al mentioned that HPV initiation was higher among girls predominately 
Hispanic areas, 69.0% vs. 49.9%; AOR, 1.64; 95% CI [1.43–1.87] or non-Hispanic 
mixed race 60.4% vs. 49.9%; AOR, 1.30, 95% CI [1.17–1.44] compared with 
predominately non-Hispanic white areas (Henry, Stroup, Warner, & Kepka, 2016). 
Further research looks at targeting those considered to be high risk for HPV-related 





Studies on HPV Vaccination and Geographical Location  
 Regional disparities and variations in the United States are a significant barrier 
and can have an effect on HPV vaccination uptake amongst adolescents. Additionally, 
adolescent girls residing in the South were less likely to initiate the HPV vaccine then 
adolescent girls residing in the Northeast. As a whole, the study showed that adolescents 
from the northeastern regions of the United States were 1.62 times more likely to get 
vaccinated then adolescents in southern regions of the United States, p = 0.000, OR 1.62, 
95% CI [1.38, 1.90] (Sriram & Ranganathan, 2019). Lastly, collaborative communication 
and geographical location were investigated to determine an effect. A study showed a 
statistically significant effect when comparing the Northeast and the Southern 
geographical location in regards to collaborative communication, it was found that 
parents were more likely to report collaborative communication if they did not reside in 
the South, OR 1.38, 95% CI [1.06, 1.81] (Moss, Gilkey, Rimer, & et al, 2016). Henry, & 
et al mentioned that there was a significant difference in HPV initiation among girls in 
high poverty communities compared with girls in low poverty communities 61.1% vs. 
52.4%, AOR, 1.18; 95% CI [1.04–1.33] (Henry, Stroup, Warner, & Kepka, 2016).  
Conclusion 
Previous research has found a wealth of information regarding barriers to 
vaccination. Provider recommendation is positively correlated with parent’s willingness 
to increase HPV vaccination approval. Race and geographical location was also found to 
have a significant effect on HPV vaccination uptake amongst adolescents in the United 





HPV uptake. In order to complete the aforementioned, it was important to identify the 
areas that show significance. 
Identifying provider types that are more successful in vaccinating against HPV in 
geographical locations and races that are thriving will provide the most valuable 
information. This study endeavored to contribute to the field of public health by 
identifying the provider-types, regions and races with the most success in HPV 
vaccination, so that we can identify a target audience to learn from and reciprocate the 
educate to others within the field. This will enable a more effective vaccination strategy 
and intervention, and an increase in vaccination across all, races, geographical locations, 
and provider types. This will also result in the prevention of cancer, and the saving of 
lives.  
In Chapter 3, I will discuss my research design, planned methodology, population, 






Chapter 3: Research Method 
Introduction  
In Chapters 1 and 2, details surrounding HPV vaccination, the vaccination 
recommendations for HPV, and the purpose and rationale for this research study were 
discussed. As mentioned previously, the purpose of this quantitative study was to 
determine if certain races and provider-locations in specific regions of the United States 
have better HPV vaccine uptake in adolescents, taking into account the importance of 
determining specific racial and relational factors that may lead to a higher HPV 
vaccination rate for possible further research on increased HPV uptake strategies. 
Determining these factors can identify what strategies have the potential to aid in an 
increase in HPV vaccination uptake, which will ultimately lead to addressing barriers that 
may exist and a decrease in HPV infection.  In Chapter 2, the literature review discussed 
the known barriers of HPV vaccination and the possible implications for the low 
vaccination rate; additionally, I discussed the gap in literature and detailed the current 
literature on the topic. In this chapter, I discuss research design and the rationale for using 
a quantitative methodology. I also detail the target population, data collection and data 
analysis procedures, instrumentation, and threats to validity. 
Research Design and Rationale 
The overall purpose of this study was to examine the factors of race, provider-
location type, and region of the United States, and whether there is a significant effect on 
HPV vaccine uptake among adolescents. I used a cross-sectional research design, as the 





and factors associated with it at a specific point in time (Sacred Heart University Library, 
n.d.).  
The results acquired from this study can be used to inform public health and 
health promotion strategies to increase HPV vaccination uptake amongst adolescents. In 
this study, I used a quantitative methodology and conducted a binary logistic regression 
analysis to determine the effect of race, provider-location type, and region of the United 
States, on HPV vaccine uptake among adolescents. This type of analysis will help to 
determine statistical significance amongst these factors in a cohesive manner. Secondary 
data from the National Immunization Survey (NIS) was used to address the research 
questions. From this survey, I retrieved the HPV data for adolescents, as well as data on 
the targeted demographics of said adolescents. There were no time and resource 
constraints with this design choice. 
Methodology 
Population  
The target population for this study consisted of adolescents between the ages of 
13 and 17 living in the United States at the time of the survey in year, 2018. The target 
population also consisted of adolescents across the United States in this age group, who 
have received one or more doses of HPV vaccination. The NIS data has a sample size of 
approximately 38,706. According to CDC, sample estimates and actual population values 
may differ; however, the difference is quantified through the 95% confidence interval and 
therefore still representative of the adolescent population in the United States (Centers for 






The secondary data source for this study was the NIS. The NIS conducted the first 
survey in April 1994 (Centers for Disease Control and Prevention, 2018). NIS data is 
retrieved via telephone interviews with parents or guardians in all 50 states, the District 
of Columbia, and some U.S. territories (Centers for Disease Control and Prevention, 
2018). The process of selection begins with cell phone numbers being randomly selected 
and called to enroll age-eligible teens from the household (Centers for Disease Control 
and Prevention, 2018). Names of participants’ children’s vaccination providers are 
requested along with permission to contact them; this is needed in order to confirm the 
vaccination information provided by the parent (Centers for Disease Control and 
Prevention, 2018). Once permission is obtained from the parent, a questionnaire is mailed 
to each child’s vaccination provider(s) to collect vaccine information regarding the 
number of doses and dates of vaccine administration (Centers for Disease Control and 
Prevention, 2018). Inclusion criteria for the NIS applied to parents of students between 
the ages of 13-17 who participated in the survey. Exclusion criteria was applied to 
parents of students who did not participate in the study.  
The NIS survey was selected for this study because it is inclusive of the target 
population and adolescent vaccines, specifically HPV vaccination. Through the use of the 
NIS I obtained current, population-based, state estimates of HPV vaccination coverage 
(Centers for Disease Control and Prevention, 2018). The NIS is conducted by the Centers 
for Disease Control and Prevention, which shows the reliability and validity of this data 





https://www.cdc.gov/vaccines/imz-managers/nis/data-tables.html; no formal permission 
was required to use or access this data. 
Sampling Procedures 
The NIS sample is representative of the adolescent population in the United 
States. As mentioned previously, the sample size for the NIS is approximately 38,706. 
Determining the appropriate sample size was important to ensure a valid sample and 
statistical significance.  Using the Raosoft calculator the recommended sample size 
produced is 381, with a margin of error of 5%, a confidence level of 95%, a population 
size of 38,706 and a response rate of 50% (Raosoft, 2004). 
Instruments 
 As mentioned previously, the instrument that was used for this study is the 2018 
NIS. The survey is administered to parents of adolescents across the United States, in 
reference to several vaccines including HPV vaccination; approximately four questions 
will be analyzed. 
Operationalization  
 The effects of the following factors were analyzed: 
Race, which is an independent variable, is defined as one of the following: White, Black 
or African American, American Indian, Alaska Native, Asian, Native Hawaiian or other 
Pacific Islander. Provider-location type, which is an independent variable that is defined 
as the location of the vaccine provider. Region of the United States, which is also an 
independent variable in this study and is defined as West, Midwest, Northeast, and South. 
The aforementioned variables were used to determine the effect on the dependent 





The survey questions used provided the demographic information, such as race, at which 
provider-location the HPV vaccination was received, and the state in which the 
adolescent received the HPV vaccine. Questions from the NIS that were used for this 
study can be found in Appendix A. Variables and questions used form the NIS are listed 
in Table 2 below.  
Table 2 
NIS Teen Data Variables and Questions  
Variable Name  Variable type Statistical test Question  
TIS_BHPV2  
 
Dependent variable Binary regression  Has [TEEN] ever 






Binary regression Please tell me all the 
types of places 
where [TEEN] has 
received an HPV 
shot. READ IF 
NECESSARY: This 
question is referring 
to the location of the 
vaccine provider, not 
to the location on the 
body where the shot 






Binary regression Now, I am going to 
read a list of 
categories. Please 
choose one or more 
of the following 
categories to 
describe [TEEN]’s 
race. Is [TEEN] 









Hawaiian or other 






Binary regression In what city, county 




Data Analysis Plan 
 The Statistical Package for the Social Sciences (SPSS) was used to conduct the 
data analysis. Questions that were not relevant were removed from the data sample; 
coding identifiers were available.  
Research Questions 
A qualitative research methodology was considered however, it would be very 
difficult to capture attitudes and beliefs associated with HPV rates amongst adolescents 
across the country. Therefore, the quantitative methodology was the preferred 
methodology for this study. As mentioned previously, using a quantitative research 
approach, I looked to address the following research questions:  
 Research Question 1: What is the effect of race and region of the United States, 
on HPV vaccine uptake in adolescents? 
The dependent variable in this research question is HPV uptake in adolescents, 





test that will be used for this research question is a binary logistic regression analysis to 
determine if there is an effect.  
Research Question 2: What is the effect of race and provider-location type on 
HPV vaccine uptake in adolescents? 
The dependent variable in this research question is HPV vaccine uptake in 
adolescents, the independent variables are race and provider-location type. The statistical 
test that will be used for this research question is a binary logistic regression analysis to 
determine if there is an effect. 
 Research Question 3: What is the effect of region of the United States and 
provider-location type, on HPV vaccine uptake in adolescents? 
The dependent variable in this research question is HPV vaccine uptake in 
adolescents, and the independent variables are region of the United States and provider-
location type. The statistical test that will be used for this research question is a binary 
logistic analysis to determine if there is an effect. 
 Research Question 4: Does race modify the effect of region of the United States, 
on HPV vaccine uptake in adolescents?  
The dependent variable in this research question is HPV vaccine uptake in 
adolescents, and the independent variables are race and region of the United States. The 
statistical test that was used for this research question is a binary logistic regression 
analysis which aimed to determine am estimate of an effect of region of the United States 
while adjusting for race in HPV vaccine uptake in adolescents. 
Research Hypotheses 





H01: There is no effect of race and region of the United States, on HPV vaccine 
uptake in adolescents. 
H0a: There is a significant effect of race and region of the United States, on HPV 
vaccine uptake in adolescents. 
H01: There is no effect of race and provider-location type, on HPV vaccine uptake 
in adolescents. 
H0a: There is a significant effect of race and provider-location type, on HPV 
vaccine uptake in adolescents. 
H01: There is no effect of region of the United States and provider-location type, 
on HPV vaccine uptake in adolescents. 
H0a: There is a significant effect of region of the United States and provider-
location type, on HPV vaccine uptake in adolescents. 
H01: Race does not modify the effect of region of the United States, on HPV 
vaccine uptake in adolescents. 
H0a: Race significantly modifies the effect of region of the United States, on HPV 
vaccine uptake in adolescents. 
In order to address the aforementioned research questions, a combination of 
various statistical approaches were used. Descriptive statistics, and p-value was used to 
determine association, a binary logistic regression was used to determine if there is a 
statistically significant effect and a Pearson chi-square test was used to determine 
whether a relationship between the variables existed. As mentioned previously, a binary 
logistic regression was used to predict the value of a variable, in this case the dependent 





more other variables, in this case, the independent variables, which are race, provider-
location type and region of the United States (Laerd Statistics, 2018). The significance 
level was set at 0.05 with a 95% confidence interval. Covariates were not included in this 
data analysis. 
Threats to Validity 
  A discussion of both internal and external validity was very important to assess 
the validity of the results presented in a study. Threats to external validity are any factors 
within a study that reduce the generalizability of the results (Laerd Statistics, 2012a). The 
threats to internal validity are factors that can affect the outcome (Laerd Statistics, 
2012b). Quantitative research designs can make outcomes and generalizations from 
the sample being studied. The outcomes and generalizations include the population in 
which the sample is drawn, and/or across populations (Laerd Statistics, 2012a).  
Selection biases is an example of threats to internal and external validity. The NIS 
sample used can have selection/volunteer bias as the individuals sampled may be from 
parents who only use cell phones, and not parents who have landlines. The 
aforementioned example can be a threat to validity as this group of parents may not be 
random enough to be representative of the population. An additional, example of 
selection bias is the age of the sample may be disproportionate, the response rate for older 
parents with adolescent children may be different from younger parents with adolescent 
children, causing a threat to validity as this may cause the result to be invalidated as not 





 The threats to construct validity were also important to address as this aspect 
focused on the generalizability from my study and whether it actually measured HPV 
uptake amongst adolescents (Trochim, 2020).  
Ethical Procedures 
Ethical considerations were made with the use of secondary data, as this data was 
publicly available, and permissions are not required. In regard to confidentiality, the data 
was aggregated, and no identifying information was available. The data file was stored in 
SPSS on my computer until the approval of dissertation, IRB approval of storage policy 
was confirmed. Participation in the survey was voluntary and participants were made 
aware of their choice, verbal consent was given.  
Summary 
 In Chapter 3, I detailed the research design and rationale of this study, along with 
the methodology to include the target population. I also detailed the sampling and 
sampling procedures, the dataset to be used, instrumentation and operationalization of the 
data, threats to validity and ethical procedures. In Chapter 4, I will discuss the data 






Chapter 4: Results 
Introduction 
The purpose of this quantitative study was to determine if there is an effect of race, 
provider-location type, and region on HPV vaccine uptake amongst adolescents. The predictor 
variables included race, provider-location type, and geographical/census region, while the 
dependent variable is HPV uptake amongst adolescents. This study examined whether there is a 
significant effect between the predictor variables and the dependent variable. The results 
determined areas where HPV vaccination in adolescence is increasing and areas in which HPV 
vaccination is lagging. Data for this study were acquired from the 2018 NIS-Teen survey to 
answer my research questions; the data were analyzed using SPSS version 25. In this chapter, I 
discuss the data collection methods, detail the research questions and hypotheses, discuss the 
statistical assumptions, and relay the results of the study. 
Discrepancies 
I intended to use a multiple regression analysis to answer my research questions. 
However, it was determined that the best fit for this study would be the use of a binary logistic 
regression, as my dependent variable is dichotomous. Additionally, in reference to the provider-
location type variable, there were a total of 20,139 (52%) missing variables, however, the power 
analysis deemed the amount of responses received were sufficient for this study.  
Dependent Variable 
The dependent variable in this study included receipt of HPV vaccination. This 
variable was ascertained by asking respondents if their adolescent child had received an 







 The independent variables included race, which used the categories of White only, Black 
only, and Other/multiple races. Another independent variable was geographical/census region, 
which used the categories of Northeast, Midwest, South and West. The independent variable of 
provider-location type used the categories of all public facilities, all private facilities, all hospital 
facilities, all STD/School/Teen clinic, mixed, unknown, and missing.  
Research Questions and Hypotheses 
The research questions and hypotheses for this study included the following:  
RQ1: What is effect of race and region of the United States, on HPV vaccine uptake in 
adolescents? 
H01: There is no statistically significant effect of race and region of the United 
States, on HPV vaccine uptake in adolescents. 
H0a: There is a statistically significant effect between race and region of the 
United States, on HPV vaccine uptake in adolescents. 
RQ2: What is the effect of race and provider-location type on HPV vaccine uptake in 
adolescents? 
H02: There is no statistically significant effect of race and provider-location type, 
on HPV vaccine uptake in adolescents. 
H0a: There is a statistically significant effect of race and provider-location type, 
on HPV vaccine uptake in adolescents. 
RQ3: What is the effect of region of the United States and provider-location type on HPV 





H03: There is no statistically significant effect of region of the United States and 
provider-location type on HPV vaccine uptake in adolescents. 
H0a: There is a statistically significant effect of region of the United States and 
provider-location type on HPV vaccine uptake in adolescents. 
RQ4: Does race modify the relationship of region of the United States on HPV vaccine 
uptake in adolescents?  
H04: Race does not modify the relationship of region of the United States on HPV 
vaccine uptake in adolescents. 
H0a: Race significantly modifies the relationship of region of the United States on 
HPV vaccine uptake in adolescents. 
Data Collection 
The secondary data source for this study was the 2018 NIS. The NIS survey was 
selected for this study because it is inclusive of the target population and adolescent 
vaccines, specifically HPV vaccination. Through the usage of the NIS, I obtained current, 
population-based state estimates of HPV vaccination coverage (Centers for Disease 
Control and Prevention, 2018). Data from the NIS is retrieved through telephone 
interviews with parents or guardians in all 50 states, the District of Columbia, and some 
U.S. territories (CDC, 2018). The cell phone numbers are randomly selected and the 
parents and guardians of eligible children are asked for the names of their children’s 
vaccination providers and permission to follow-up with them to verify information 
provided. Once the survey is completed, a questionnaire is mailed to each child’s 
vaccination provider(s) to collect the information on vaccination type, dose number, dates 





(CDC, 2018). The NIS is conducted by the Centers for Disease Control and Prevention, 
which shows the reliability and validity of this data source.  
Results 
 This section details descriptive statistics, results of the chi-square test, and results of the 
binary logistic regression analyses. 
Descriptive Statistics  
 A summary of the descriptive statistics can be found in Tables 3 through 9. The 
participants’ age range is 13 to 17 years and the sample size is n = 38,706. The survey’s 
respondents were primarily of White race adolescents, of which accounted for 29,531 (76.3%) of 
the study population; Black adolescents accounted for 3,975 (10.3%), and other/multiple race 
adolescents accounted for 5,200 (13.4%) of the study population. Of the census regions, 7,096 
(18.3%) of respondents were from the Northeast region, 8,194 (21.2%) were from the Midwest 
region, 15,382 (39.7%) were from the South, and 8,034 (20.8%) of the study population were 
from the West. Amongst the provider-location types, 2,399 (6.2%) reported All Public, 2,012 
(5.2%) reported All Hospital, 8,080 (20.9%) reported All Private, 490 (1.3%) reported All 
STD/Teen/School, 3,330 (8.5%) reported mixed, 2,286 (5.9%) reported unknown, and 20,139 
(52.0%) were missing. Table 6 shows HPV uptake amongst adolescents responses received from 
survey responders. Of the survey responders, 14,084 (40.3%) reported No HPV shot and 20,896 
(59.7%) responded Yes HPV shot. This sample size is appropriate and proportionate to the larger 
population, as the Raosoft calculator recommended a sample size of 381 and a population size of 
38,706.  
Table 7 shows the crosstabulation of race and HPV vaccination uptake. The results show 





other/multiple race adolescents (60.3%) to receive an HPV vaccine. Table 8 shows the 
crosstabulation of census region. The results show that adolescents living in the Northeast region 
(66.1%) were more likely than adolescents in the South (57.7%), Midwest (60.7%), and West 
(57.1%) to receive an HPV vaccination. Table 9 shows the crosstabulation of provider-location 
type, and the results show that adolescents seeking care at hospitals (70.3%), and private 
facilities (66.4%) were more likely than public (59.4%), STD/School/Teen clinic (59.1%), and 
mixed facilities (65.8%) to receive an HPV vaccine. 
Table 3 
Race  
Variable N Valid % Cumulative % 
Race    
White only 29,531 76.3 76.3 
Black only 3,975 10.3 86.6 
Other/multiple 5,200 13.4 100 






Variable N Valid % Cumulative % 
Census region    
Northeast 7096 18.3 18.3 
Midwest 8194 21.2 39.5 
South 15382 39.7 79.2 
West 8034 20.8 100 













    
All public  
facilities 
2399 6.2 12.9 12.9 
All hospital  
facilities 
2012 5.2 10.8 23.8 
All private  
facilities 
8080 20.9 43.5 67.3 
All STD/school 
/teen clinics 
490 1.3 2.6 69.9 
Mixed  
3300 8.5 17.8 87.7 
Unknown 
2286 5.9 12.3 100 
Missing 
20139 52.0   
Total 
38,706 100 100  
 
    
Table 6 
HPV Vaccination Uptake  
 Frequency % Valid % Cumulative % 
No HPV  
Shot 
14084 36.4 40.3 40.3 
Yes HPV  
Shot 
20896 54.0 59.7 100.0 
Total 34980 90.4 100  
 
Table 7 
Crosstabulation of Race and HPV Vaccination Uptake  
Variable Category           HPV vaccine uptake Total  
  No HPV shot Yes HPV shot  
Race White only 10931 15976 26907 
 % within race 40.6% 59.4% 100% 
 % within HPV 
uptake 
77.6% 76.5% 76.9% 





 Black only  1345 2175 3520 
 % within race 38.2% 61.8% 100% 
 % within HPV 
uptake 
9.5% 10.4% 10.1% 
 % of total 3.8% 6.2% 10.1% 
 other + multiple 1808 2745 4553 
 % within race 39.7% 60.3% 100% 
 % within HPV  
uptake 
12.8% 13.1% 13.0% 
 % of total 5.2% 7.8% 13.0% 
 Total 14084 20896 34980 
 % within race 40.3% 59.7% 100% 
 % with HPV  
uptake 
100% 100% 100% 
 % of total 40.3% 59.7% 100% 
 
Table 8 
Crosstabulation of Region and HPV Vaccination Uptake  
Variable  Category                 HPV vaccine uptake Total  
  No HPV shot Yes HPV shot  
Region Northeast  2164 4214 6378 
 % within region 33.9% 66.1% 100% 
 % within HPV  
Uptake 
15.4% 20.2% 18.2% 
 % of Total 6.2% 12.0% 18.2% 
 Midwest 2952 4550 7502 
 % within region  39.3% 60.7% 100% 
 % within HPV  
Uptake  
21.0% 21.8% 21.4% 
 % of Total 8.4% 13.0% 21.4% 
 South 5869 8013 13882 
 % within region 42.3% 57.7% 100% 
 % within HPV  
Uptake 
41.7% 38.3% 39.7% 
 % of Total 16.8% 22.9% 39.7% 
 West 3099 4119 7218 
 % within region 42.9% 57.1% 100% 
 % within HPV 
Uptake 
22.0% 19.7% 20.6% 
 % of Total 8.9% 11.8% 20.6% 
Total  14084 20896 34980 
 % within region 40.3% 59.7% 100% 
 % within HPV 
Uptake 





 % of Total 40.3% 59.7% 100% 
     
 
Table 9 
Crosstabulation of Provider-Location Type and HPV Vaccination Uptake  
Variable Category           HPV Vaccine Uptake Total 
  No HPV shot Yes HPV shot  
Provider Location  All Public  
Facilities 
847 1241 2088 
 % within Provider  
Location 
40.6% 59.4% 100% 
 % within HPV 
Uptake 
14.4% 11.1% 12.3% 
 % of Total 5.0% 7.3% 12.3% 
 All Hospital  
Facilities 
558 1320 1878 
 % within Provider  
Location 
29.7% 70.3% 100% 
 % within HPV  
Uptake 
9.5% 11.8% 11.0% 
 % of Total 3.3% 7.7% 11.0% 
 All Private  
Facilities 
2503 4939 7442 
 % within Provider 
Location 
33.6% 66.4% 100% 
 % within HPV  
Uptake 
42.6% 44.3% 43.7% 
 % of Total 14.7% 29.0% 43.7% 
 All STD/School/ 
Teen Clinics 
179 259 438 
 % within Provider 
Location 
40.9% 59.1% 100% 
 % within HPV 
Uptake 
3.0% 2.3% 2.6% 
 % of Total  1.1% 1.5% 2.6% 
 Mixed 1055 2028 3083 
 % within Provider 
Location 
34.2% 65.8% 100% 
 % within HPV 
Uptake 
17.9% 18.2% 18.1% 
 % of Total 6.2% 11.9% 18.1% 
 Unknown 738 1373 2111 
 % within Provider 
Location 





 % within HPV  
Uptake 
12.6% 12.3% 12.4% 
 % of Total 4.3% 8.1% 12.4% 
  5880 11160 17040 
Total % within Provider 
Location 
34.5% 65.5% 100% 
 % within HPV 
Uptake 
100% 100% 100% 
 % of Total 34.5% 65.5% 100% 
 
Statistical Assumptions: Pearson Chi-Square Test 
 Statistical assumptions should be met when conducting a chi-square test. The first 
assumption is that two variables should be measured at an ordinal or nominal level, this 
assumption was met in this study as the independent variables of race, region, and provider-
location type are each, categorical (Laerd Statistics, 2018). The next assumption is that the 
variables should consist of two or more categorical, independent groups, this assumption was 
met in this study as race has three independent groups, census region has four independent 
groups, and provider-location type has six independent groups (Laerd Statistics, 2018).  
Statistical Assumptions: Binary Logistic Regression 
 Statistical assumptions are to be met when conducting the binary logistic regression. The 
first assumption indicated that the dependent variable should be measured on a dichotomous 
scale, this was met as the dependent variable HPV vaccine received is a dichotomous variable 
with answers of either yes or no. The second assumption indicated that there are one or more 
independent variables that are either continuous or categorical, this assumption has been met as 
the independent variables of race, census region, and provider-location type are each considered 
categorical (Laerd Statistics, 2018). The third assumption indicated there should be 
independence of observations and the dependent variable should have mutually exclusive and 





independent were mutually exclusive (Laerd Statistics, 2018). The fourth assumption indicated 
that there needs to be a linear relationship between any continuous variable, of which is not 
applicable in this study as the independent variables were categorical (Laerd Statistics, 2018). It 
was verified that the binary logistic regression assumptions have been met.  
Binary Logistic Regression Analysis 
A binary logistic regression analysis was conducted to examine the effect of race, and 
region on HPV vaccine uptake amongst adolescents; race, and provider-location type on HPV 
vaccine uptake amongst adolescents; region and provider-location type on HPV vaccine uptake 
amongst adolescents and the interaction of race and region on HPV vaccine uptake in 
adolescents. The binary logistic regression was selected for this study because I will be using 3 
independent variables and a dichotomous dependent variable. Table 10 shows how many cases 
were included in the analyses, how many cases were excluded or missing and how many cases 
were in total. There were a total of 38,706 total cases, 34,980 were included in the analysis and 
3,726 were missing. Additionally, the results of the chi-square analysis showed statistical 
significance. The model, containing each of the predictor variables, resulted in X2(11, n = 
38,706) = 165.4, p < .001. All predictors provided a unique statistically significant contribution 
to the model (see Table 11).  
Table 10 
Case Summary 
Selected Cases  N % 
 Included in Analysis  34,980 90.4 
 Missing Cases  3,726 9.6 
 Total  38,706 100 








 Chi-square Df p 
Model 165.399 11 .000 
 
Statistical Analysis Findings 
Research Question 1 (RQ1): What is effect of race and region of the United States, on HPV 
vaccine uptake in adolescents? 
To address RQ1, a binary logistic regression and chi-square test was conducted to 
determine whether there was an effect of race and region of the United States, on HPV vaccine 
uptake amongst adolescents and whether there was a relationship between the variables. The chi-
square test containing the race and census region predictor variables, was significant overall, 
X2(5, n = 38,706) = 164.951, p < .000. Although, the model was significant, Black race (p=.113), 
other/multi race (p=.282), and the Western region (p=.509), did not have a significant effect on 
HPV uptake amongst adolescents. As shown in Table 12, both predictors provided unique 
statistically significant contributions to the model. Specifically, White race adolescents were 
shown to be significant (p=.010), as well as the Northeast (p=.000), Midwest (p=.000), and the 
Southern (p=.000) regions each of which were shown to be significant. Additionally, the model 
explained .006 (Nagelkerke R2) of the variance of HPV vaccination and correctly classified 
59.7% of cases.  
In this model, the odds ratio for other/multiple race adolescents were 1.05 times those of 
White race adolescents to receive an HPV vaccine, however, this difference was also not 
statistically significant. Also, in this model, adolescents living in the Midwest were 1.5 times 





in the South were 1.2 times those of adolescents living in the Northeast to have received an HPV 
vaccine. The Western region was shown not have a significant effect in comparison to the 
Northeast region (see Table 12). 
Table 12 
Binary Logistic Regression: Race and Census Region 
        95% C.I. for Odds Ratio 
  B S.E. Wald df P Odds Ratio   
Race1    9.154 2 .010    
 Black  -.052 .033 2.511 1 .113 .949 .890 1.012 
 Other/ 
Multiple 
.050 .047 1.157 1 .282 1.052 .960 1.152 
Region2    154.049 3 .000    
 Midwest .378 .036 112.027 1 .000 1.460 1.361 1.566 
 South .148 .034 19.395 1 .000 1.160 1.086 1.239 
 West .020 .030 .436 1 .509 1.020 .962 1.081 
Constant  .323 .036 82.588 1 .000 1.382   
Note. 1 - White only is the reference group; 2 – Northeast is the reference group 
Research Question 2 (RQ2): What is the effect of race and provider-location type on HPV 
vaccine uptake in adolescents?  
To address RQ2, a binary logistic regression was conducted to determine whether there 
was an effect of race and provider-location type on HPV vaccine uptake in adolescents. The chi-
square model, containing the race and provider-location type, predictor variables, was 
significant, X2(7, n = 38,706) = 85.72, p < .000. Although, the model was statistically significant, 
other/multiple race adolescents (p=.305), and all STD/School/Teen clinic (p=.181) did not have a 
statistically significant impact on the effect of HPV vaccine uptake amongst adolescents. As 
shown in Table 13, various predictors provided a unique statistically significant contribution to 
the model. Specifically, the White race (p=.000), and Black race (p=.002) are shown to be 





(.000), and a Mixture of facilities (p=.021) were statistically significant with a p<.05.  The model 
explained .007 (Nagelkerke R2) of the variance of HPV vaccination and correctly classified 
65.5% of cases. Table 13 depicts the binary regression summary. 
In this model, the results show that Black race adolescents were 0.86 times less likely 
than White race adolescents to receive an HPV vaccine. Additionally, other/multiple race 
adolescents were 1.1 times those of White race adolescents to receive an HPV vaccine, however, 
this difference was not statistically significant (see Table 13). The results also show that all 
hospital providers were 0.78 times less likely than those at all public facilities to have received 
an HPV vaccine. All private facilities were 1.3 times those of all public facilities to have 
received an HPV vaccine. Moreover, all STD/school/teen clinics were 1.1 times those of all 
public facilities to have received an HPV vaccine, however, this difference was deemed not 
statistically significant. Lastly, mixed facilities only .78 times less likely than those of all public 
facilities to have received an HPV vaccine.  
Table 13 
Binary Logistic Regression: Race and Provider-Location Type  
        95% C.I. for Odds Ratio 
  B S.E. Wald df p Odds Ratio   
Race1    22.253 2 .000    
 Black only -.155 .049 9.852 1 .002 .857 .778 .944 
 Other/ 
Multiple 
.075 .073 1.054 1 .305 1.077 .934 1.242 
Provider 
Location2 
   67.180 5 .000    
 All Hospital 
Facilities 
-.245 .064 14.747 1 .000 .782 .690 .887 
 All Private 
Facilities 
.246 .068 13.032 1 .000 1.279 1.119 1.462 
 All STD/School/ 
Teen Clinics 
.069 .052 1.786 1 .181 1.072 .968 1.187 
 Mixed -.247 .107 5.293 1 .021 .781 .633 .964 





Constant  .730 .063 136.120 1 .000 2.076   
Note. 1 - White only is the reference group; 2 – All Public Facilities is the reference group  
Research Question 3 (RQ3): What is the effect of region of the United States and 
provider-location type, on HPV vaccine uptake in adolescents? 
To address RQ3, a binary logistic regression was conducted to determine whether there 
was an effect of region of the United States and provider-location type on HPV vaccine uptake in 
adolescents. The model, containing the region and provider-location type, predictor variables, 
was significant, X2(8, n = 38,706) = 130.016, p < .000. As mentioned previously, the model was 
statistically significant, however, the Southern region (p=.129), the Western region (p=.779), All 
STD/School/Teen Clinic (p=.409), and a mixture of clinics (p=.458) did not have a statistically 
significant impact on the effect of HPV vaccination amongst adolescents. As shown in Table 14, 
both predictors provided unique statistically significant contributions to the model. Specifically, 
the Northeast region (p=.000), and the Midwest region (p=.000) is shown to be significant. All 
public facilities (p=.000), All hospital facilities (p=.000), and All private facilities (p=.003) are 
shown to be significant. The model explained .010 (Nagelkerke R2) of the variance of HPV 
vaccination and correctly classified 65.5% of cases. Table 14 depicts the binary regression 
summary. 
In this model, the results show that adolescents residing in the Midwest were 1.4 times 
those adolescents residing in the Northeast to receive an HPV vaccine. Additionally, adolescents 
residing in the South were 1.1 times those of adolescents residing in the Northeast to receive an 
HPV vaccine, however, this difference was not statistically significant (see Table 14). 
Table 14 also shows that adolescents who seek healthcare in all hospital facilities were 





private facilities were 1.2 times those at all public facilities to have received an HPV vaccine. 
Adolescents who attend all STD/school/teen clinics were 1.0 times those at all public facilities to 
have received an HPV vaccine, however, this difference was not deemed to be statistically 
significant. Lastly, adolescents that attend mixed facilities are 1.1 times those at all public 
facilities to have received an HPV vaccine, however the difference was also not deemed to be 
statistically significant.  
Table 14 
 Binary Logistic Regression: Census Region and Provider-Location Type 
        95% C.I. for Odds Ratio 
  B S.E. Wald df P Odds Ratio   
Region1    65.082 3 .000    
 Midwest .356 0.53 44.701 1 .000 1.428 1.286 1.585 
 South .074 .049 2.299 1 .129 1.077 .978 1.186 
 West -.012 .043 .079 1 .779 .988 .907 1.075 
Provider  
Location2 
   51.176 5 .000    
 All Hospital 
Facilities 
-.229 .064 12.866 1 .000 .795 .701 .901 
 All Private 
Facilities 
.201 .069 8.582 1 .003 1.222 1.069 1.398 
 All STD/ 
School/Teen 
Clinics 
.043 .052 .681 1 .409 1.044 .943 1.156 
 Mixed .0444 .060 .550 1 .458 1.045 .930 1.174 
Constant          
Note. 1 - Northeast is the reference group; 2 – All Public Facilities is the reference group 
Research Question 4 (RQ4): Does race modify the relationship of region of the United 
States, on HPV vaccine uptake in adolescents? 
To address RQ4, a binary logistic regression was conducted to determine the 
significance of the interaction between race and region on HPV vaccine uptake amongst 





significant, X2(1, n = 38,706) = 13.851, p < .000. The model containing the interaction shows 
that the interaction between race and region was also statistically significant with a (p=.000) 
(See Table 15). The model explained .001 (Nagelkerke R2) of the variance of HPV 
vaccination and correctly classified 59.7% of cases. 
Table 15 
Binary Logistic Regression: Race x Region 
       95% C.I. for Odds Ratio  
 B S.E. Wald Df p Odds Ratio   
Race by Region -.016 .004 13.900 1 .000 .984 .976 .992 
Constant .453 .019 564.940 1 .000 1.572   
  
Summary 
In this chapter, NIS-teen data was used to determine the effect of race, provider-location 
type, and region on HPV vaccination uptake among adolescents. The data has been identified 
and analyzed to answer the research questions presented in this study. The sample size of the 
data was 38,706, missing data was removed from the recoded HPV vaccination receipt, of which 
34,980 were included in the analysis.  
As a result of the findings, the chi-square test conducted shows that race and region had 
a statistically significant effect on HPV vaccination uptake among adolescents. The chi-square 
test also shows that race and provider-location type had a statistically significant effect on HPV 
vaccination uptake amongst adolescents. Additionally, region and provider-location type results 
from the chi-square test showed a statistically significant effect on HPV vaccination uptake 
amongst adolescents. The interaction between race and region was also found to be statistically 





The binary logistic regression analysis conducted for RQ1 showed statistical 
significance amongst adolescents of White race, and adolescents residing in the Northeast, 
Midwest, and South. The binary logistic regression analysis conducted for RQ2 showed 
statistical significance amongst adolescents of White race and Black race, and adolescents 
who acquired HPV vaccination at public facilities, hospital facilities, private facilities and 
mixed facilities. The binary logistic regression analysis conducted for RQ3 showed statistical 
significance amongst adolescents in the Northeast, Midwest, who accessed services at all 
public facilities, all hospital facilities, and all private facilities. Lastly, the binary logistic 
regression analysis conducted for RQ4 showed statistical significance with the interaction of 
race and region on HPV vaccination uptake amongst adolescents.  
As a result of the analysis, the null hypothesis that there is no statistically significant 
effect of race and region of the United States on HPV vaccine uptake in adolescents was 
rejected and the alternative hypothesis was accepted. Additionally, the null hypothesis stating 
that there is no statistically significant effect of race and provider-location type on HPV vaccine 
uptake in adolescents was rejected and the alternative hypotheses was accepted. The null 
hypothesis that indicates that there is no statistically significant effect of region of the United 
States and provider-location type on HPV vaccine uptake in adolescents was also rejected and 
the alternative hypothesis was accepted. Lastly, the null hypothesis that indicated race does not 
modify the relationship of region of the United States, on HPV vaccine uptake in adolescents 
was also rejected, and the alternative hypothesis was accepted. 
In Chapter 4 the results of the study were presented, in Chapter 5, I will detail the 











Chapter 5: Discussion 
Introduction 
The purpose of this quantitative study was to determine if there was an effect of 
race, provider-location type, and region of the United States on HPV vaccine uptake 
amongst adolescents. Research conducted previously looked into communication factors, 
such as provider recommendation and its positive correlation of HPV vaccination 
willingness. However, there is limited research on specific factors that may affect HPV 
vaccine uptake in adolescents, hence the reasoning for this study. This study used 2018 
NIS Teen data to answer the four research questions. The sample size of the survey 
consisted of 38,706 respondents. The theoretical framework used for this study was the 
Health Belief Model, which helped explain the importance of attitude and strategies that 
can be used to increase the intent and uptake of HPV vaccination amongst adolescents. A 
Pearson Chi-square test was used to analyze the significance of the model, and a binary 
logistic regression was used to address each of the research questions. 
Summary of Key Findings 
There were several key findings from this study. Descriptive statistics were 
conducted and found that survey respondents were primarily of White race (76.3%), were 
primarily from the Southern region (39.7%) and seek healthcare at all private providers 
(20.9%).  It was determined that there was a statistically significant effect amongst each 
of the independent variables, of which include race, provider-location type and region, on 
the dependent variable of HPV vaccine uptake amongst adolescents. There was a 
statistically significant effect amongst race and region on HPV vaccine uptake amongst 





There was also a statistically significant effect amongst race and provider-location 
type. There was also a statistically significant effect among region and provider-location 
type and amongst the interaction between race and region on HPV vaccination uptake 
amongst adolescents. I will discuss the interpretation of the findings, limitations of the 
study, recommendations, and implications of social change. 
Interpretation of the Findings 
HPV Vaccination and Race 
Siriam and Ranganathan (2019) conducted a study that showed Hispanics were 
1.47 times more likely than other races to receive HPV vaccination. Burdette et al. (2017) 
also conducted a survey that showed that minority adolescent males had a higher rate of 
HPV vaccine initiation and non-Hispanic whites had a lower HPV vaccine initiation. 
Henry et al. (2016) conducted a study which resulted in higher HPV vaccination among 
girls in predominately Hispanic areas: 60.4% compared with predominately White areas, 
49.9%. According to this study, when analyzing the data for race and provider-location 
type, White race adolescents and Black race adolescents were shown to be statistically 
significant, while the other/multiple race  adolescents was shown to not have a 
statistically significant effect on HPV vaccination uptake amongst adolescents. 
Additionally, when controlling for race and region, the White race was shown to be 
statistically significant, while Black race and other/multiple race adolescents, showed to 
not have a statistically significant effect on HPV vaccination uptake among adolescents.    
 This study shows that when assessing for different variables, there may also be a 
difference in the effect.  For instance, in this study White race was statistically significant 





further research as to what strategies are working within the White race and Black race 
adolescents that received HPV vaccination at public, hospital and private facilities and 
what strategies are working in the White race adolescents in the Northeastern, Midwest, 
and Southern regions.  
HPV Vaccination and Geographical Region 
 Siriam and Ranganathan (2019) conducted a study that showed adolescent girls 
residing in the South were less likely to initiate the HPV vaccine compared to adolescent 
girls residing in the Northeast region. This study confirmed the findings, as the 
Northeastern region had a significant effect on HPV vaccination rate as compared to 
adolescents residing in the South when controlling for provider-location type. Moss et al. 
(2016) also conducted a survey that found that parents were more likely to report 
collaborative communication if they did not reside in South OR 1.38, 95%, CI [1.06, 
1.81].  
Within this study, when analyzing for region and provider-location type, the 
Northeast region and Midwest region were shown to have a statistically significant effect 
on HPV vaccination uptake amongst adolescents. It was also determined that when 
analyzing for both region and race, the Northeast region, Midwest region and the 
Southern region were shown to be significant. Both analyses showed a statistical 
significance amongst the Northeast and Midwest region, therefore, determining the 
strategies used within those regions, to implement in the states within the Southern and 





HPV Vaccination and Provider-Location Type 
 Garbutt et al. (2018) conducted a study that determined that provider 
recommendations in the primary care setting informs implementation strategies which 
results in increased vaccination of HPV vaccine. Katz et al. (2016) determined that 
further research should look into the strategies to support providers and collaboration at 
the practice level (Katz, Bogart, Fu, & et al, 2016). Within this study, the analysis of race 
and provider-location type resulted in statistical significance amongst all public facilities, 
all hospital facilities, all private facilities, and mixed facilities. Additionally, the analysis 
of region and provider-location type resulted in statistical significance amongst all public 
facilities, all hospital facilities and all private facilities.  
This study also shows specifically which provider-location types, cohesively 
along with other predictor variables, including race and region, have a statistically 
significant effect on HPV vaccination uptake amongst adolescents. This will allow 
researchers to determine which provider-location types have an increased HPV 
vaccination uptake amongst adolescents, which will ultimately assist underperforming 
provider locations determine and implement strategies to increase HPV vaccination.  
Theoretical Framework 
The theoretical framework used in this study was the HBM. This study found 
statistical significance among various cohesive factors, amongst race, region, and 
provider-location type. The statistical significance results proven within this study, 
amongst race and region, race and provider-location type, region and provider-location 
type, and the interaction between race and region, shows that the attitudes and 





pertaining to HPV vaccination uptake amongst adolescent. Additionally, the results of the 
study provides the groundwork for identifying strategies used by the factors of race, 
provider-location and region, resulting in an increased HPV vaccination amongst 
adolescents. The specific factors included, White race adolescents,  receiving HPV 
vaccination in the Northeast, South and Midwest regions, White race and Black race 
adolescents receiving HPV vaccination at public, hospital, private and mixed facilities; 
and adolescents that reside in the Northeast, and Midwest region, that receive HPV 
vaccination at public, private or hospital facilities. Conducting further research and 
identifying the strategies that are used among the aforementioned variables and 
ultimately applying them to the underperforming strategies will address each construct of 
the HBM and increase HPV vaccination in adolescents, among all races, all regions, and 
all provider-location types. 
Limitations of the Study 
The study showed that 52% of provider-location types were missing. This is a 
limitation of the study as it is more than half of the participants. If this information were 
included in the survey, it may have changed the trajectory of the provider-location type 
results. There is also a limitation on positively concluding that increased HPV 
vaccination among adolescents were a definite result of race, region, and provider-
location type.  
An additional limitation of this study is generalizability. Generalizability is the 
degree to which the results of the sample of participants used for a research study reflect 
what the results would be “in the real world” (Frey, 2018). Generalizability in this study 





limitations from individuals who do not have access to a landline telephone, which was 
the way in which the survey was conducted. Ultimately, this can result in the results 
being unrepresentative of the population, which results in lack of generalizability. Lastly, 
the final limitation is the reporting of inaccuracies in responses, this may cause validity 
and reliability issues; CDC attempts to prevent these issues by conducting follow-up with 
providers following the survey. 
Recommendations 
The recommendations of this study, include further research conducted to identify 
specific strategies among White and Black race adolescents who received HPV 
vaccinations at public, hospital, and private facilities. Additionally, further research 
should identify specific strategies among White race adolescents residing in the 
Northeast, Midwest, and Southern region. Further research should look into the strategies 
used for adolescents residing in the Northeast and Midwest that received an HPV vaccine 
at a public, hospital and private facilities. This research will aid in increasing HPV 
vaccination rates among adolescents other/multiple race adolescents, and adolescents 
residing in the West, and those seeking care in STD/school/teen clinics and mixed 
facilities.  
There should also be a cohesive strategy used across the races, regions, and 
provider-location type, to obtain a cohesive result of increased HPV vaccination amongst 
adolescents. Education, awareness, and accessibility should be further researched as this 






This study can help target the states, providers, and races across the country that 
have an increased HPV vaccination rates and those that are lagging, and can aid in 
determining whether a cohesive effect exists, and whether there are specific strategies in 
the well performing HPV vaccination areas that can be relayed and transferred to the 
HPV vaccination underperforming areas. 
Implications 
 It has been defined that the premise of positive social change is the intent of 
creating and applying ideas, strategies, and actions to promote the worth, dignity, and 
development of individuals, communities, organizations, institutions, cultures, and 
societies, through a series of processes (Walden University, 2020). In this study there are 
several implications for positive socials changes. The potential impact for social change 
at the organizational level can be accomplished with identifying races, provider-location 
types, and regions that have increased HPV vaccination and understanding the strategies 
that can be relayed to underperforming variables. This will enable increased performance 
for those variables that are lagging and ultimately an increase in HPV vaccination 
amongst adolescents which will also lead to individualized social change.  
 This study will aid in identifying areas of increased HPV vaccination rate, and 
ultimately lead to an understanding of the strategies that are most successful for further 
research; this will help increase HPV vaccination across the United States, consistently. 







The HPV vaccine is a significant public health advancement that has the ability to 
prevent recurring HPV infection and ultimately save many lives. This results of this study 
showed that race and region had a statistically significant effect on HPV vaccination 
uptake amongst adolescents; specifically, White race, the Northeast, Midwest, and the 
Southern regions were shown to be statistically significant. This study also showed that 
race and provider-location type had a statistically significant effect on HPV vaccine 
uptake amongst adolescents, specifically, the White and Black race was shown to be 
significant, in addition to all public facilities, all hospital facilities, all private facilities, 
and a mixture of facilities. This study also showed that provider-location type and region 
were shown to be statistically significant; specifically, the Northeast region, and the 
Midwest region were shown to be significant, in addition to all public facilities, all 
hospital facilities, and all private facilities. Lastly, the results of this study showed that 
the interaction between race and region were found to be statistically significant in its 
effect on HPV vaccination amongst adolescents. 
This study was conducted to determine the various factors that have an effect on 
HPV vaccination uptake amongst adolescents. The areas where there is an increased level 
of HPV uptake were determined using a binary logistic regression, and assisted with 
determining the areas where HPV vaccination rates were lagging. This ultimately will aid 
in determining the strategies being used that are positively increasing HPV vaccination 
rates in adolescents, and sharing those strategies with the areas that are lagging. This 
study provides the background information and foundation base for further research in 





those areas. HPV is vital for the health of men and women, and it is my thought that with 
increased HPV vaccination rates in adolescence, will undoubtedly lead to the prevention 
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Appendix A: Questions from the 2018 NIS Used for This Study 
Questions 1 will provide variables related to HPV vaccination. 
Q1: Has [TEEN] ever received HPV shots? 
1. Yes 
2. No 
3. Don’t Know 
4. Refused 
Questions 5 will provide the variables related to race.  
Q5: Is [TEEN] White, Black or African American, American Indian, Alaska Native, 
Asian, Native Hawaiian or Pacific Islander? 
1. White 
2. Black/African American  
3. American Indian  
4. Alaska Native  
5. Asian  
6. Native Hawaiian  
7. Pacific Islander  
8. Other  
9. Don’t Know 
10. Refused 





Questions 9-12 will provide the variables related to Region of the United States. 
Q9: What is your zip code? 
1. ____ 
2. Don’t Know 
3. Refused 
Q10: In what city, county, and state do you live? 
1. Enter City 
2. Enter County 
3. Enter State 
Q11: To confirm, you live in [CITY}, [COUNTY], [STATE]. Is that correct? 
      1. Yes 
       2. No  
Q12: To confirm, I have your zip code as ______. Is that correct? 
1. Yes 
2. No 
3. Don’t Know 
4. Refused 





Q13: Please tell me all the types of places where [TEEN} has received an HPV shot: This 
question is referring to the location of the vaccine provider, not to the location on the 
body where the shot was given.  
1. Doctor’s Office  
2. Emergency Room 
3. Health Department  
4. Clinic or Health Center 
5. Hospital-Based Clinic  
6. While Hospitalized 
7. Other Medically Related Place  
8. Pharmacy, Drug Store, or Supermarket Pharmacy  
9. Workplace  
10. Elementary/Middle/High School 
11. Other Non-medically related place  
12. Mall Outreach  
13. Village Outreach (Guam) 
14. Don’t Know  
15. Refused  
